MINNEAPOLIS, April 10 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its first quarter 2006 financial results before the market opens on Thursday, April 20, 2006. The management team of Enpath Medical will host a conference call to discuss the results beginning at 1:30 P.M. Central Time, also on Thursday, April 20, 2006. To participate, please call 800-257-7087 for domestic callers and 303-262-2125 for international callers. A recording of the conference call will be available approximately one hour after the conclusion of the call and will be accessible for seven days. To access the replay, please dial 1-800-405-2236 for domestic callers and 303-590-3000 for international callers; please reference the passcode 11058273#. The conference call will also be webcast live on the company's web site, http://www.enpathmed.com/ , and may be accessed by clicking on the 1st Quarter 2006 Earnings Call icon. An audio replay will be archived on the Enpath website for one year. About Enpath Medical Enpath Medical, Inc., headquartered in Plymouth, Minnesota, is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its products include venous vessel introducers, epicardial and endocardial stimulation leads, safety needles and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation and hearing restoration markets. Its products are sold worldwide through partnering relationships with other medical device companies. DATASOURCE: Enpath Medical, Inc. CONTACT: Investors, Doug Sherk or Jennifer Beugelmans, +1-415-896-6820, or Media, Steve DiMattia, +1-646-277-8706, all of EVC Group Web site: http://www.enpathmed.com/

Copyright

Enpath (NASDAQ:NPTH)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas Enpath.
Enpath (NASDAQ:NPTH)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas Enpath.